About: Aptamer-conjugated multi-walled carbon nanotubes as a new targeted ultrasound contrast agent for the diagnosis of prostate cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Aptamer-conjugated multi-walled carbon nanotubes as a new targeted ultrasound contrast agent for the diagnosis of prostate cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 12 November 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) im Januar 2018 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована у 2018 (uk) article scientifique publié en 2018 (fr) artículu científicu espublizáu en payares de 2018 (ast) 2018 թվականի նոյեմբերի 12-ին հրատարակված գիտական հոդված (hy) scientific article published on 12 November 2018 (en)
publication date	wds:Q59810368-7767123E-4511-4D95-ADE6-5368098DD769
publication date	2018-11-12 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q59810368-D34BC435-006F-4DBE-98A0-D5AF53B748D5
language of work or name	English
exact match	wds:Q59810368-A3D0973C-3804-444A-849E-AEB49FBEBEF9
exact match	https://scigraph.springernature.com/pub.10.1007/s11051-018-4407-z
cites work	wds:Q59810368-046A240F-3A1E-4F9D-A23A-41429A7B3DA3 wds:Q59810368-048D4663-D90D-4A7B-8B9B-AD047AEEEE69 wds:Q59810368-052A5D15-2113-46FD-8B28-D6BE257FDD05 wds:Q59810368-172D4845-9B19-4AB4-A0FD-899D25F5E281 wds:Q59810368-1FC3058B-D425-4376-9994-CA0FEC850F2B wds:Q59810368-2138F63C-D9A2-4522-8339-A61222B4AFD4 wds:Q59810368-2614FD5C-BF40-4661-AAEA-389CF82E6434 wds:Q59810368-30C8AA89-F329-4526-AC49-DD0522D6A7F5 wds:Q59810368-36EF3660-4A53-42C7-8CC8-FFC0D1CA22D5 wds:Q59810368-3C5644A7-4EEF-41A7-B859-BBAE56B81C79 wds:Q59810368-3D2DEC7D-B3E3-4903-8C5C-3838F28D1411 wds:Q59810368-42452BB0-C100-4780-B413-C398648ADD39 wds:Q59810368-4AC122FD-8AD4-489C-9416-00B1877AA444 wds:Q59810368-4DFB5F5D-22DE-4C5A-B097-D456A16FF4C8 wds:Q59810368-4FC93745-66D0-4194-B464-18DDF5E87C97 wds:Q59810368-4FCC5F40-DF6E-474B-9BAE-FD3ACB4F8C6C wds:Q59810368-51954ED7-AB43-48EC-BDB7-C8DEB662C426 wds:Q59810368-54DA1888-DFC0-4C8A-968A-C9EED0FE002C wds:Q59810368-5990CF8A-3EBC-4C10-A244-6ED373A524C0 wds:Q59810368-5BB013D8-4EE3-4125-A27C-42C1FAC37829 wds:Q59810368-640D4E5F-DD94-49AA-8E0E-0413E23EE560 wds:Q59810368-74F7E3C2-5D28-41CD-A9E4-6D3E2DEA5D06 wds:Q59810368-7C26D25B-76B1-4A33-823B-0015AE7E687B wds:Q59810368-8E0C89F4-D86F-4307-809E-C21C966EAE62 wds:Q59810368-8F6B716F-8C1C-425B-8F3F-05C675B069AE wds:Q59810368-8F836E0B-64A6-4E7F-A45E-149199CBEA75 wds:Q59810368-9C7D4BB6-0233-4C0F-934D-8F721D5204F1 wds:Q59810368-A35C0EC0-1270-44E8-8496-3BCFC78F29DE wds:Q59810368-A6719527-1F0C-41D7-A57B-306F659218EB wds:Q59810368-B2E60479-9C7F-4760-AA56-B512E42FB24A wds:Q59810368-B46FCA4C-A858-4033-9911-9C42D925E494 wds:Q59810368-C6E53C47-DF31-4D7F-9E2D-B45AFFF8051A wds:Q59810368-CDA15055-1B73-4FCC-BCDC-DC9394384330 wds:Q59810368-CE280B50-21F3-4D37-A917-9A9A4D272886 wds:Q59810368-CE6CC538-9DB3-45AC-908A-54021EE32D45 wds:Q59810368-D4003C0E-0C48-40DE-92B5-D4E6F70410C1 wds:Q59810368-DA8C031D-6C07-4D99-98BD-F8C4FDBC0E2B wds:Q59810368-E19CB35F-0D56-49A5-8A80-BA28EE60AC62 wds:Q59810368-EDDBDE10-9971-432D-B0BD-989DFFF88068
cites work	Functionalized multiwalled carbon nanotubes as ultrasound contrast agents Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Pancreatic cancer--EUS and early diagnosis Construction and in vitro/in vivo targeting of PSMA-targeted nanoscale microbubbles in prostate cancer Prostate stem cell antigen antibody-conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex. Nanoparticles as contrast agents for in-vivo bioimaging: current status and future perspectives Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery Ultrasonic Nanobubbles Carrying Anti-PSMA Nanobody: Construction and Application in Prostate Cancer-Targeted Imaging Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics Cancer statistics, 2016 Noncovalent sidewall functionalization of single-walled carbon nanotubes for protein immobilization Labeling tumor cells with fluorescent nanocrystal-aptamer bioconjugates Polyethyleneimine functionalized single-walled carbon nanotubes as a substrate for neuronal growth. Gene therapy of carcinoma using ultrasound-targeted microbubble destruction Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005 Contemporary role of systematic prostate biopsies: indications, techniques, and implications for patient care Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research PEGylated anticancer-carbon nanotubes complex targeting mitochondria of lung cancer cells Applications of aptamers in targeted imaging: state of the art Should Hypoechoic Lesions on Transrectal Ultrasound Be Sampled During Magnetic Resonance Imaging-targeted Prostate Biopsy? A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer. Translocation of Bioactive Molecules through Carbon Nanotubes Embedded in the Lipid Membrane. Aptamers in targeted nanotherapy Using RNA aptamers and the proximity ligation assay for the detection of cell surface antigens
author name string	wds:Q59810368-0108E7E8-61BB-4A25-B404-F00CB73733C0 wds:Q59810368-3CBFF4CD-4C1C-4E2B-832E-DE3EA1672E0D wds:Q59810368-5A2ED115-6F87-4D29-B869-83FE33BB724E wds:Q59810368-764D5EF2-F316-489C-A19F-2C38D2E415FE wds:Q59810368-83C893A5-2828-43A9-B791-4E9462F1A8A1
author name string	Zhongjian Chen Chuling Hu Chunai Gong

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software